Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duavee for Perimenopausal Depression
NCT03740009Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bazedoxifene in perimenopausal depression, sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Change in Frontostriatal Reactivity to Reward During MID fMRI Task at 3 weeks and Mood and Anxiety Symptom Questionnaire - Anhedonic Depression at 4 weeks. Started Jan 2019; status: completed.
02
Drugs
bazedoxifene
03
Conditions
perimenopausal depression
Beyond the preview
Go deeper on NCT03740009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740009.